Studying How Viruses Trigger Flare-Ups in Chronic Lung Disease
Follows adults with chronic lung disease, sampling them when well and during flare-ups.
Key facts
- Who runs it
- Imperial College London
- Where
- London, United KingdomSee the site
- Trial code
- Registry title
- Exploring How Viral Infections Affect People With Chronic Lung Disease
- Status
- Recruiting
- People taking part
- 180 people, planned
- Started
- 1 Nov 2024
- Expected to end
- Apr 2027
- Type of study
- Observational
- Record updated
- 14 July 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with long-term lung disease such as COPD or bronchiectasis who had a flare-up in the last year. It studies how viruses trigger flare-ups.
- Age
- 18 Years and older
- Sex
- All sexes can join.
- Disease stage
- Chronic airway disease (for example COPD and bronchiectasis) confirmed by a doctor.
- Earlier treatment
- At least one flare-up in the last year that needed antibiotics and/or corticosteroids.
Main reasons for not taking part
- Cannot complete daily symptom diaries or attend clinical assessments
- Flare-up within 4 weeks of joining the study
- Clinical instability at the time of joining
- Pregnancy
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Adults with a physician confirmed diagnosis of chronic airway disease (e.g. COPD and bronchiectasis) according to established diagnostic criteria; AND
- Prior history of exacerbation within last year (defined as requiring antibiotic and/or corticosteroids)
Who cannot take part
- Inability to complete daily symptom diaries and/or attend for clinical assessments
- Exacerbation within 4 weeks of study recruitment and/or clinical instability at the time of recruitment
- Pregnancy
Where in United Kingdom
- Royal Brompton HospitalLondon, United KingdomContact: Anand ShahTaking people
About the trial
What the trial wants to find out
Many people with chronic lung disease have disease flare-ups. It was previously believed that these were mainly caused by bacteria but recent evidence suggests that viruses could be an important trigger. This study will recruit volunteers with chronic lung disease and take samples both when well (at baseline) and during flare-ups (exacerbations) to better understand the role of viruses in triggering exacerbations and also how the immune response is affected. The researchers will follow the volunteers\' progress for up to two years. Whenever they get unwell they will take some samples (nose swabs, finger prick testing, phlegm sample) and post them to the researchers. Then, they will come in for a visit for more samples (blood tests, further swabs) and a review.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prospective Cohort Study to Understand Impact of Viral Infection in Chronic Lung Disease
- Plain-language title
- Studying How Viruses Trigger Flare-Ups in Chronic Lung DiseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 14 July 2025